CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kratzke, R. A.
Right arrow Articles by Kaye, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kratzke, R. A.
Right arrow Articles by Kaye, F. J.

Cell Growth & Differentiation, Vol 4, Issue 8 629-635, Copyright © 1993 by American Association of Cancer Research


ARTICLES

RB-mediated tumor suppression of a lung cancer cell line is abrogated by an extract enriched in extracellular matrix

RA Kratzke, E Shimizu, J Geradts, JL Gerster, S Segal, GA Otterson and FJ Kaye
NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20889.

To examine whether the expression of retinoblastoma (RB) protein could mediate tumor suppression in a lung carcinoma cell line carrying multiple genetic defects, we transfected the Rb gene into a non-small cell lung cancer cell line with absent RB protein. We observed that the stable expression of a functional RB product was associated with a decreased efficiency of soft agar cloning and partial suppression of tumorigenicity in nude mice. The suppression of tumorigenicity was marked when 10(6) cells were injected into the flanks of nude mice but was less prominent when 10(7) cells were injected. RB-mediated tumor suppression, however, was consistently blocked by preincubation of the transfected cells with an extract enriched with an extracellular matrix (Matrigel). Analysis of tumors harvested from nude mice showed that they continued to express detectable levels of human RB protein which retained functional E1A binding activity and nuclear localization. RB-mediated inhibition of soft agar cloning was also blocked in a dose-dependent manner by the addition of Matrigel. These observations demonstrate that the expression of wild-type RB may suppress certain parameters of tumorigenicity in lung carcinoma cells that contain multiple genetic alterations. In addition, the reversal of tumor suppression by an extract enriched in basement membrane components may offer clues for further investigations into the mechanism of RB-mediated tumor suppression.


This article has been cited by other articles:


Home page
Cancer Res.Home page
B. A. Jacobson, M. D. Alter, M. G. Kratzke, S. P. Frizelle, Y. Zhang, M. S. Peterson, S. Avdulov, R. P. Mohorn, B. A. Whitson, P. B. Bitterman, et al.
Repression of Cap-Dependent Translation Attenuates the Transformed Phenotype in Non-Small Cell Lung Cancer Both In vitro and In vivo.
Cancer Res., April 15, 2006; 66(8): 4256 - 4262.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Eason and G. Blanck
High Level Class II trans-Activator Induction Does Not Occur with Transient Activation of the IFN-{gamma} Signaling Pathway
J. Immunol., January 15, 2001; 166(2): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. A. Otterson, W.-d. Chen, A. B. Coxon, S. N. Khleif, and F. J. Kaye
Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function
PNAS, October 28, 1997; 94(22): 12036 - 12040.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.